China and the U.S. plan to highlight joint efforts to crack down on fentanyl smuggling, addressing an opioid epidemic that President Trump has asked his counterpart Xi Jinping to help alleviate as part of broader trade talks.
More than $1.7 billion in goods cross the border each day from Mexico into the U.S., with more than 70% traveling by truck. For businesses on both sides of the border, getting goods from point A to B can be a complex, confusing and expensive process.
Regulators want to reduce U.S. dependence on foreign-made pharmaceutical ingredients, as a wave of recalls has raised questions about the safety of the global drug-supply chain.
In the food industry today, it's the "age of transparency." But what does that mean, when it comes to what consumers really want from producers and sellers? Katy Jones, chief marketing and strategy officer with FoodLogiQ, has answers.
Krenar Komoni, founder and chief executive officer of Tive Inc., reveals some surprising facts about the progress of supply-chain visibility — or lack of it.
Supply chains don't just need to be visible — they also need to be transparent. Alexis Bateman, director of MIT Sustainable Supply Chains, explains the difference.
While there are similar regulations and overlapping requirements governing both Mexico and U.S. customs import processes, there are drastic differences that savvy shippers should be aware of.
China’s aggressive campaign to bring down drug prices is leading to a “vicious cycle” and will prevent the emergence of a national pharmaceutical champion, said one of the country’s biggest drug makers.
Given that Johnson & Johnson’s lawyers made public statements this month that the company’s talc-based products were free of asbestos, the recall couldn’t come at a worse time.